CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed
Drug / intervention
Alternate site blood glucose testingprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00207207
NCT00207207Phase 1Completed
CompareCT.gov

Randomized Trial to Assess the Effect of Using Alternate Site Blood Glucose Testing Versus Finger-Tip Testing on Long-Term Glycemic Control.

Boston Medical Center·interventional·Posted Sep 21, 2005·Updated Feb 11, 2009

In Brief

A Phase 1 clinical trial evaluating Alternate site blood glucose testing for Diabetes Mellitus. Completed, across 1 site.

Detailed Summary

The objective is to assess the effect of using ASBG (alternate site blood glucose) versus FTBG (finger tip blood glucose) testing on long-term glycemic control in diabetics. Since ASBG measurements appear to lag behind FSBG measurements at times of changing glucose concentration, it is possible that ASBG measurements will yield lower postprandial readings than FTBG, potentially causing a negative impact on long-term control. It is also possible that since ASBG is reportedly more comfortable than FTBG testing, it's use might improve adherence to testing and improve long term control.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Mellitus
CountriesUnited States
CollaboratorsDepartment of Health and Human Services, Food and Drug Administration (FDA)

Timeline

Phase 1CompletedFinished
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 21, 2005
Enrollment StartJul 1, 2003
Primary CompletionOct 1, 2005
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 20.8 years ago

Interventions

Alternate site blood glucose testingprocedure